251 related articles for article (PubMed ID: 36416036)
1. Surfactant administration in preterm babies (28-36 weeks) with respiratory distress syndrome: LISA versus InSurE, an open-label randomized controlled trial.
Mishra A; Joshi A; Londhe A; Deshmukh L
Pediatr Pulmonol; 2023 Mar; 58(3):738-745. PubMed ID: 36416036
[TBL] [Abstract][Full Text] [Related]
2. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
Kaniewska U; Gulczyńska E
Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
[TBL] [Abstract][Full Text] [Related]
3. Less Invasive Surfactant Administration (LISA) vs. Intubation Surfactant Extubation (InSurE) in Preterm Infants with Respiratory Distress Syndrome: A Pilot Randomized Controlled Trial.
Pareek P; Deshpande S; Suryawanshi P; Sah LK; Chetan C; Maheshwari R; More K
J Trop Pediatr; 2021 Aug; 67(4):. PubMed ID: 34595526
[TBL] [Abstract][Full Text] [Related]
4. Surfactant administration methods for premature newborns: LISA vs. INSURE comparative analysis.
Mansouri M; Servatyari K; Rahmani K; Sheikhahmadi S; Hemmatpour S; Eskandarifar A; Rahimzadeh M
J Neonatal Perinatal Med; 2024; 17(2):233-239. PubMed ID: 38759030
[TBL] [Abstract][Full Text] [Related]
5. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial.
Gupta BK; Saha AK; Mukherjee S; Saha B
Eur J Pediatr; 2020 Aug; 179(8):1287-1293. PubMed ID: 32462483
[TBL] [Abstract][Full Text] [Related]
6. Less invasive surfactant administration via infant feeding tube versus InSurE method in preterm infants: a randomized control trial.
Anand R; Nangia S; Kumar G; Mohan MV; Dudeja A
Sci Rep; 2022 Dec; 12(1):21955. PubMed ID: 36535971
[TBL] [Abstract][Full Text] [Related]
7. Nasal intermittent positive pressure ventilation during less invasive surfactant administration in preterm infants: An open-label randomized controlled study.
Dani C; Napolitano M; Barone C; Manna A; Nigro G; Scarpelli G; Bonanno E; Gatto S; Cavigioli F; Forcellini C; Petoello E; Beghini R; Ciarcià M; Fusco M; Mosca F; Lavizzari A; Gitto E; Barbuscia L; Betta P; Mattia C; Corvaglia L; Vedovato S; Vento G; Maffei G; Falsaperla R; Lago P; Boni L; Lista G;
Pediatr Pulmonol; 2024 Apr; 59(4):1006-1014. PubMed ID: 38441525
[TBL] [Abstract][Full Text] [Related]
8. Five-year single center experience on surfactant treatment in preterm infants with respiratory distress syndrome: LISA vs INSURE.
Buyuktiryaki M; Alarcon-Martinez T; Simsek GK; Canpolat FE; Tayman C; Oguz SS; Kutman HGK
Early Hum Dev; 2019 Aug; 135():32-36. PubMed ID: 31229792
[TBL] [Abstract][Full Text] [Related]
9. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
[TBL] [Abstract][Full Text] [Related]
10. Less Invasive Surfactant Administration (LISA) Versus INSURE Method in Preterm Infants: a Retrospective Study.
Dini G; Santini MG; Celi F
Med Arch; 2024; 78(2):112-116. PubMed ID: 38566872
[TBL] [Abstract][Full Text] [Related]
11. Less Invasive Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome.
Halim A; Shirazi H; Riaz S; Gul SS; Ali W
J Coll Physicians Surg Pak; 2019 Mar; 29(3):226-330. PubMed ID: 30823947
[TBL] [Abstract][Full Text] [Related]
12. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis.
Aldana-Aguirre JC; Pinto M; Featherstone RM; Kumar M
Arch Dis Child Fetal Neonatal Ed; 2017 Jan; 102(1):F17-F23. PubMed ID: 27852668
[TBL] [Abstract][Full Text] [Related]
13. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effect of surfactant administration during nasal continuous positive airway pressure with that of nasal continuous positive airway pressure alone on complications of respiratory distress syndrome: a randomized controlled study.
Nakhshab M; Tajbakhsh M; Khani S; Farhadi R
Pediatr Neonatol; 2015 Apr; 56(2):88-94. PubMed ID: 25264154
[TBL] [Abstract][Full Text] [Related]
15. Lung recruitment improves the efficacy of intubation-surfactant-extubation treatment for respiratory distress syndrome in preterm neonates, a randomized controlled trial.
Yang Y; Yan W; Ruan M; Zhang L; Su J; Deng H; Li M
BMC Pediatr; 2022 Jan; 22(1):14. PubMed ID: 34980047
[TBL] [Abstract][Full Text] [Related]
16. Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome.
Ramos-Navarro C; Sánchez-Luna M; Zeballos-Sarrato S; González-Pacheco N
J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2704-2710. PubMed ID: 30526187
[No Abstract] [Full Text] [Related]
17. Less invasive surfactant administration versus intubation-surfactant-extubation in the treatment of neonatal respiratory distress syndrome: a systematic review and meta-analyses.
Silveira RC; Panceri C; Munõz NP; Carvalho MB; Fraga AC; Procianoy RS
J Pediatr (Rio J); 2024; 100(1):8-24. PubMed ID: 37353207
[TBL] [Abstract][Full Text] [Related]
18. Surfactant therapy in premature babies: SurE or InSurE.
Jena SR; Bains HS; Pandita A; Verma A; Gupta V; Kallem VR; Abdullah M; Kawdiya A; On Behalf Of Sure Group
Pediatr Pulmonol; 2019 Nov; 54(11):1747-1752. PubMed ID: 31424177
[TBL] [Abstract][Full Text] [Related]
19. Comparison of INSURE method with conventional mechanical ventilation after surfactant administration in preterm infants with respiratory distress syndrome: therapeutic challenge.
Nayeri FS; Esmaeilnia Shirvani T; Aminnezhad M; Amini E; Dalili H; Moghimpour Bijani F
Acta Med Iran; 2014; 52(8):596-600. PubMed ID: 25149882
[TBL] [Abstract][Full Text] [Related]
20. Less Invasive Surfactant Administration: A Viewpoint.
Mani S; Rawat M
Am J Perinatol; 2024 Jan; 41(2):211-227. PubMed ID: 36539205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
